1. Home
  2. RCMT vs HELP Comparison

RCMT vs HELP Comparison

Compare RCMT & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$28.85

Market Cap

200.2M

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$6.17

Market Cap

233.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RCMT
HELP
Founded
1971
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.2M
233.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RCMT
HELP
Price
$28.85
$6.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$36.00
$51.50
AVG Volume (30 Days)
69.1K
1.3M
Earning Date
04-03-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
N/A
EPS
0.52
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$11.89
N/A
Revenue Next Year
$12.46
N/A
P/E Ratio
$54.81
N/A
Revenue Growth
5.83
N/A
52 Week Low
$17.26
$3.76
52 Week High
$32.50
$8.55

Technical Indicators

Market Signals
Indicator
RCMT
HELP
Relative Strength Index (RSI) 65.71 66.28
Support Level $17.77 $5.76
Resistance Level $32.39 $6.26
Average True Range (ATR) 1.21 0.44
MACD 0.32 0.22
Stochastic Oscillator 81.64 73.11

Price Performance

Historical Comparison
RCMT
HELP

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: